Lene E. Johansen

3.9k total citations
7 papers, 206 citations indexed

About

Lene E. Johansen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Lene E. Johansen has authored 7 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Lene E. Johansen's work include Advanced Breast Cancer Therapies (5 papers), Cancer-related Molecular Pathways (3 papers) and Breast Cancer Treatment Studies (2 papers). Lene E. Johansen is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), Cancer-related Molecular Pathways (3 papers) and Breast Cancer Treatment Studies (2 papers). Lene E. Johansen collaborates with scholars based in Denmark, Sweden and Australia. Lene E. Johansen's co-authors include Henrik J. Ditzel, Martin A.B. Hedegaard, Søren Hassing, Jürgen Popp, Christoph Krafft, Carla L. Alves, Sidse Ehmsen, Martin Bak, Mikkel G. Terp and Daniel Eliáš and has published in prestigious journals such as Nature Communications, Analytical Chemistry and Hypertension.

In The Last Decade

Lene E. Johansen

7 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lene E. Johansen Denmark	6	93	87	76	61	42	7	206
Nara de Matos Granja United States	5	65 0.7×	137 1.6×	139 1.8×	118 1.9×	89 2.1×	5	358
See Wee Lim Singapore	4	19 0.2×	23 0.3×	86 1.1×	43 0.7×	18 0.4×	5	164
Masakatsu Kotsuma Japan	8	58 0.6×	69 0.8×	54 0.7×	4 0.1×	6 0.1×	15	244
Holly Sullivan United States	5	151 1.6×	35 0.4×	157 2.1×	14 0.2×	3 0.1×	11	359
Chunlai Lu China	7	132 1.4×	86 1.0×	381 5.0×	7 0.1×	6 0.1×	9	487
Stephanie Ling United Kingdom	7	18 0.2×	59 0.7×	148 1.9×	21 0.3×	6 0.1×	16	257
Gautham Gampa United States	9	74 0.8×	105 1.2×	105 1.4×	4 0.1×	2 0.0×	11	263
Leslie R. Euceda Norway	11	33 0.4×	47 0.5×	239 3.1×	4 0.1×	18 0.4×	15	336
Hanna Najgebauer United Kingdom	4	18 0.2×	38 0.4×	183 2.4×	16 0.3×	2 0.0×	6	223

Countries citing papers authored by Lene E. Johansen

Since Specialization

Citations

This map shows the geographic impact of Lene E. Johansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lene E. Johansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lene E. Johansen more than expected).

Fields of papers citing papers by Lene E. Johansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lene E. Johansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lene E. Johansen. The network helps show where Lene E. Johansen may publish in the future.

Co-authorship network of co-authors of Lene E. Johansen

This figure shows the co-authorship network connecting the top 25 collaborators of Lene E. Johansen. A scholar is included among the top collaborators of Lene E. Johansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lene E. Johansen. Lene E. Johansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Ehmsen, Sidse, Sofie Traynor, N I Nissen, et al.. (2025). RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer. Frontiers in Oncology. 14. 1497093–1497093. 1 indexed citations

Peluso, A. Augusto, Stefan J. Kempf, Thiago Verano‐Braga, et al.. (2022). Quantitative Phosphoproteomics of the Angiotensin AT ₂ -Receptor Signaling Network Identifies HDAC1 (Histone-Deacetylase-1) and p53 as Mediators of Antiproliferation and Apoptosis. Hypertension. 79(11). 2530–2541. 7 indexed citations

Alves, Carla L., Sidse Ehmsen, Mikkel G. Terp, et al.. (2022). Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer. npj Precision Oncology. 6(1). 68–68. 47 indexed citations

Eliáš, Daniel, Carla L. Alves, Martin V. Bennetzen, et al.. (2021). MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit. npj Breast Cancer. 7(1). 2–2. 11 indexed citations

Alves, Carla L., Sidse Ehmsen, Mikkel G. Terp, et al.. (2021). Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nature Communications. 12(1). 5588–5588. 5 indexed citations

Alves, Carla L., Sidse Ehmsen, Mikkel G. Terp, et al.. (2021). Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nature Communications. 12(1). 5112–5112. 56 indexed citations

Hedegaard, Martin A.B., Christoph Krafft, Henrik J. Ditzel, et al.. (2010). Discriminating Isogenic Cancer Cells and Identifying Altered Unsaturated Fatty Acid Content as Associated with Metastasis Status, Using K-Means Clustering and Partial Least Squares-Discriminant Analysis of Raman Maps. Analytical Chemistry. 82(7). 2797–2802. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact